已發(fā)表的部分文獻(xiàn): 標(biāo)題:Serum lipid and blood pressure responses to quercetin vary in overweight patients by apolipoprotein E genotype.作者:Egert S, Boesch-Saadatmandi C, Wolffram S, Rimbach G, Müller MJ;雜志名稱:J Nutr 標(biāo)題:Combination of antithrombin and recombinant thrombomodulin modulates neutrophil cell-death and decreases circulating DAMPs levels in endotoxemic rats.作者:Iba T, Miki T, Hashiguchi N, Tabe Y, Nagaoka I;雜志名稱:Thromb Res 標(biāo)題:Anticancer potential of Tinospora cordifolia and arabinogalactan against benzo(a)pyrene induced pulmonary tumorigenesis: a study in relevance to various biomarkers作者:Mohan V, Koul A;雜志名稱:J Herbmed Pharmacol. 標(biāo)題:Role of Histone Deacetylase Inhibitor in Diabetic Painful Neuropathy.作者:Thakur V, Gonzalez MA, Parada M, Martinez RD, Chattopadhyay M;雜志名稱:Mol Neurobiol Epigentek 公司是全球領(lǐng)先的表觀遺傳學(xué)相關(guān)研究的技術(shù)創(chuàng)新者和產(chǎn)品開(kāi)發(fā)供應(yīng)商。開(kāi)發(fā)了超過(guò)700多個(gè)專利產(chǎn)品,為表觀遺傳學(xué)方面的研究和新藥研發(fā)提供全面系統(tǒng)的解決方案,涵蓋樣品制備、DNA/RNA甲基化(5-mc, 5-hmc, 5-fc, m6A)/DNMT分析、ChIP、組蛋白甲基化/乙酰化/去乙酰化/磷酸化/SUMO-等領(lǐng)域,提供小分子抑制劑、蛋白質(zhì)、抗體、以及分析試劑盒產(chǎn)品。